Back to Startups

TURN BIOTECHNOLOGIES

Bioscience & Disease Healthcare Systems Deep Tech
Bioscience & Disease Healthcare Systems Deep Tech Show less
Bioscience & Disease Healthcare Systems +1
Bioscience & Disease Healthcare Systems Deep Tech Show less
@TurnBiotech Website LinkedIn San Francisco, California, USA
About TURN BIOTECHNOLOGIES

TURN Biotechnologies specializes in mRNA-based reprogramming technologies aimed at advancing cellular therapies and regenerative medicine. The company is focused on developing innovative solutions that leverage the power of mRNA to reprogram cells for therapeutic purposes.

Business Information
Target Customers
biopharmaceutical companies research institutions healthcare providers
Industry Categories
Bioscience & Disease Healthcare Systems Deep Tech
Business Model
Revenue Model Partnerships and collaborations
Pricing Strategy N/A
Sales Channels direct sales, strategic partnerships
Funding Timeline
Round Date Amount Investors
Series B Jun 20, 2025 $150.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
Longevity0S
Longevity Decoded @Longevity0S
Jun 20, 2025

WINNERS: Cellular Reprogramming Companies ALTOS LABS: $3 billion raised, Yamanaka factor research • Jeff Bezos backing • Nobel laureate team • In vivo reprogramming trials starting 2026 TURN BIOTECHNOLOGIES: $150M Series B • mRNA-based reprogramming • First human trials

View on Twitter
Similar Startups
BioTroy Therapeutics
88% match

BioTroy Therapeutics is a biotechnology company focused on developing innovative anti-tumor therapeu...
Tcelltech
87% match

Tcelltech is a clinical-stage biopharma focused on developing immunotherapies, particularly a univer...
Orbital Therapeutics
87% match

A private biotech developing RNA-based medicines designed to reprogram cells in vivo, treating disea...
Therini Bio
87% match

Therini Bio is a biotechnology company focused on developing innovative therapeutics for neurodegene...